Commence enrollment of an observational trial assessing CFI activity and genotype
Delivered after the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 4 Mar 2021
- Due
- 30 Jun 2021
- Delivered
- July 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Commence enrollment of an observational trial in mid-2021 assessing CFI activity and genotype in patients who have diseases associated with CFI deficiency”
What we found
Evidence strength A What the grades mean
Later 10-Q and 10-K filings state that patient enrollment in the CFI-001 and CFI-002 studies commenced in July 2021, after the June 30, 2021 deadline.
-
A Catalyst Biosciences, Inc. 10-Q filed 2021-08-05
“In July 2021 we commenced patient enrollment in the screening (“CFI-001”) and natural history of disease (“CFI-002”) studies to assess CFI blood levels” ✓ confirmed on the page
-
A Catalyst Biosciences, Inc. 10-Q filed 2021-08-05
“We commenced patient enrollment in the screening (“CFI-001”) and natural history of disease (“CFI-002”) studies in July 2021” ✓ confirmed on the page
-
A Catalyst Biosciences, Inc. 10-K filed 2022-03-31
“As of February 2022 we have completed enrollment of these studies.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Commence
- Deliverable
- Observational trial assessing CFI activity and genotype (CB 4332)
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Catalyst Biosciences, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-GYRE-025164 · Corrections policy